Albert David Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Albert David Limited with three other
companies in this sector in India:
RPG Life Sciences Limited
(2019
sales of 3.30 billion Indian Rupees [US$45.76 million]
),
Amrutanjan Health Care Limited
(2.53 billion Indian Rupees [US$35.10 million]
of which 91%
was OTC Products), and
Kopran Limited
(3.58 billion Indian Rupees [US$49.61 million]
of which 48%
was Bulk Drugs).
Sales Analysis.
Albert David Limited reported sales of 3.17 billion Indian Rupees (US$43.92 million)
for the
fiscal
year ending
March of 2019.
This
represents
an
increase of 10.2%
versus 2018, when the company's sales were 2.87 billion Indian Rupees.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Albert David Limited had sales
of 2.92 billion Indian Rupees.